Antihypertensive therapy-associated hypokalemia and hyperkalemia: Clinical implications

Hypertension

Volumn 59, Issue 5, 2012, Pages 906-907

  Kotchen, Theodore A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; CHLORTALIDONE; DIURETIC AGENT; DOXAZOSIN; GLUCOSE; HYDROCHLOROTHIAZIDE; LISINOPRIL; PLACEBO; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; PROTEIN KINASE WNK1; THIAZIDE DIURETIC AGENT;

ADD ON THERAPY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DIURETIC THERAPY; DRUG EFFECT; DRUG HALF LIFE; DRUG MEGADOSE; EDITORIAL; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART PROTECTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; LOW DRUG DOSE; META ANALYSIS (TOPIC); MORBIDITY; MORTALITY; POTASSIUM BLOOD LEVEL; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; STROKE; SUDDEN DEATH; TREATMENT DURATION; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERKALEMIA; HYPERTENSION; HYPOKALEMIA; MALE; MYOCARDIAL INFARCTION;

EID: 84860214350     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.112.192526     Document Type: Editorial

References (11)

1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288:2981-2997.
2. Alderman MH, Piller LB, Ford CE, Probstfield JL, Oparil S, Cushman WC, Einhorn PT, Franklin SS, Papademetriou V, Ong ST, Eckfeldt JH, Furberg CD, Calhoun DA, Davis BR, for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Hypertension. 2012;59:926-933.
3. Goyal A, Spertus JA, Gosch K, Venkitachalam L, Jones PG, Van den Berghe G, Kosiborod M. Serum potassium levels and mortality in acute myocardial infarction. JAMA. 2012;l307:157-164.
4. Cleland JG, Dargie HJ, Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J. 1987;58:572-582. (Pubitemid 18014847)
5. MacDonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol. 2004;43:155-161. (Pubitemid 38201137)
6. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, Lemaitre RN, Wagner EH, Furberg CD. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA. 1997;277:739-745. (Pubitemid 27106227)
7. Franse LV, Pahor M, Di Bari M, Somes GW, Cushman WC, Applegate WB. Hypokalemia associated with diuretic use and cardiovascular events in the Systolic Hypertension in the Elderly Program. Hypertension. 2000; 35:1025-1030. (Pubitemid 30327250)
8. Barzilay JI, Davis BR, Cutler JA, Pressel LS, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J, for the ALLHAT Collaborative Research Group. a report from the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2006;166:2191-2201.
9. Ernst ME, Carter BL, Zheng S, Grimm RH. Meta-analysis of doseresponse characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium. Am J Hypertens. 2010;23:440-446.
10. Ernst ME, Neaton JD, Grimm RH, Collins G, Thomas W, Soliman EZ, Prineas RJ, for the Multiple Risk Factor Intervention Trial Research Group. Long-term effects of chlorthalidone versus hydrochlorothiazide on electrocardiographic left ventricular hypertrophy in the Multiple Risk Factor Intervention Trial. Hypertension. 2011;58:1001-1007.
11. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E. WNK1 kinase polymorphism and blood pressure response to a thiazide diuretic: fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment-a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Hypertension. 2005;36:758-765.